Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hanzhou
Clinical trial register · China

Clinical Trials in Hanzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine13 Sir Run Run Shaw Hospital6 The Affiliated Hospital of Hangzhou Normal University4 Sunshine Lake Pharma Co., Ltd.2 Zhejiang Cancer Hospital2
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Hanzhou

42 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
The Affiliated Hospital of Hangzhou Normal University
Observational
600
Hanzhou
2026-08-01
Not yet open
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
NCT07706010Type 2 Diabetes (T2DM), Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Hospital of Hangzhou Normal University
Observational
7,000
Hanzhou
2026-07-12
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hanzhou
2026-05-27
Not yet open
The Affiliated Hospital of Hangzhou Normal University
Observational
5,000
Hanzhou
2025-06
Not yet open
Sir Run Run Shaw Hospital
Phase 2
30
Hanzhou
2025-05-01
Not yet open
Wenzhou Medical University
Observational
60
Hanzhou
2025-04-01
Active, closed
Wenzhou Medical University
Observational
62
Hanzhou
2025-03-01
Not yet open
Tasly Biopharmaceuticals Co., Ltd.
Phase 2
80
Hanzhou
2025-02-24
Active, closed
Genmab
Phase 3
584
Guangzhou, Xi'an, Changchun, Hanzhou, Shanghai, Tianjin, Zhengzhou
2025-02-07
Recruiting
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 3
748
Hanzhou
2024-12-01
Recruiting
The Affiliated Hospital of Hangzhou Normal University
Observational
350,000
Hanzhou
2024-11
Recruiting
Zhejiang University
Early Phase 1
30
Hanzhou
2024-10-20
Active, closed
Shanghai AbelZeta Ltd.
Phase 1/2
121
Shanghai, Hanzhou
2024-09-30
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
43
Hanzhou
2024-08-31
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
36
Hanzhou
2024-08-31
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
38
Hanzhou
2024-08-31
Active, closed
Sir Run Run Shaw Hospital
Phase 3
170
Hanzhou
2024-07-29
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
188
Guli, Dongyang, Hanzhou, Jinhua, Lanxi, Yiwu
2024-07-01
Recruiting
Duk-Woo Park, MD
Not applicable
1,500
Beijing, Hanzhou
2024-06-14
Not yet open
Effectiveness of Robotic Surgery for Right Colon Cancer
NCT06421974Colon Cancer, Robotic Surgery
Sir Run Run Shaw Hospital
Not applicable
610
Hanzhou
2024-06-01
Recruiting
Lifetech Scientific (Shenzhen) Co., Ltd.
Not applicable
103
Beijing, Changsha, Chengdu, Fuzhou, Hanzhou, Kunming, Nanjing, Shanghai
2024-05-30
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Beijing, Fuzhou, Guangzhou, Zhengzhou, Nanjing, Tianjin, Hanzhou
2024-05-24
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
580
Hangzhou, Hanzhou
2024-05-01
Recruiting
First Affiliated Hospital of Zhejiang University
Observational
179
Hanzhou
2024-05-01
Recruiting
Sir Run Run Shaw Hospital
Not applicable
990
Hanzhou
2024-04-08
Recruiting
Sir Run Run Shaw Hospital
Not applicable
100
Hanzhou, Quzhou
2024-04-01
Recruiting
He Huang
Not applicable
3
Hanzhou
2023-11-15
Recruiting
Sir Run Run Shaw Hospital
Phase 2
32
Hanzhou
2023-08-02
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
1,028
Hanzhou
2023-07
Recruiting
Zhejiang Cancer Hospital
Phase 2
20
Hangzhou, Hanzhou
2023-05-05
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
400
Hanzhou
2023-03-15
Recruiting
Sunshine Lake Pharma Co., Ltd.
Phase 3
324
Hanzhou
2023-03-03
Recruiting
Study of Comparing of With and Without Sequential Therapy of S-1
NCT05813015Locally Advanced Gastric Adenocarcinoma, Chemotherapy Effect
DrugsTegafur Gimeracil Oteracil·Teysuno·Docetaxel
Zhejiang University
Phase 3
70
Hanzhou
2023-01-28
Recruiting
Sunshine Lake Pharma Co., Ltd.
Phase 1/2
133
Hanzhou
2022-10-31
Recruiting
Zhejiang Cancer Hospital
Phase 2
100
Hanzhou, Ningbo
2022-08-03
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
28
Hanzhou
2022-08-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
48
Hanzhou
2022-07-26
Recruiting
Bliss Biopharmaceutical (Hangzhou) Co., Ltd
Phase 1
288
Beijing, Changsha, Ganzhou, Hangzhou, Hanzhou, Linyi, Nanjing
2022-06-01
Recruiting
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
NCT05147467Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugLisaftoclax
Ascentage Pharma Group Inc.
Phase 2
75
Guangzhou, Haikou, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin, Hanzhou
2021-12-28
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
168
Beijing, Guangzhou, Changsha, Hohhot, Shanghai, Xi’an, Chengdu, Hanzhou
2020-01-01
Recruiting
Application of Radiomics in Breast Cancer
NCT04483804Breast Cancer, Ultrasound, Elastography, Pathology
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
2,000
Hanzhou
2018-01-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
2,000
Hanzhou
2016-06
Rows per page Showing 1–42 of 42
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/hanzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 42 of those studies with a site in Hanzhou.

How many clinical trials are recruiting in Hanzhou?

30 of the 42 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 8 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hanzhou), 42 studies
PhaseStudiesRecruitingShare
Not applicable9821.4%
Observational9421.4%
Phase 28619%
Phase 36414.3%
Phase 1/2439.5%
Phase 1337.1%
Phase 4214.8%
Early Phase 1112.4%

Most active sponsors

Lead sponsors with the most studies (Hanzhou)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine1312
Sir Run Run Shaw Hospital63
The Affiliated Hospital of Hangzhou Normal University41
Sunshine Lake Pharma Co., Ltd.22
Wenzhou Medical University20
Zhejiang Cancer Hospital22
Zhejiang University22
Ascentage Pharma Group Inc.11
Bliss Biopharmaceutical (Hangzhou) Co., Ltd11
Duk-Woo Park, MD11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.